Probiotic Escherichia coli NISSLE 1917 for inflammatory bowel disease applications

被引：0

作者：

Zhao, Zejing ^{[1
]}

Xu, Shumin ^{[1
]}

Zhang, Wangyang ^{[1
]}

Wu, Danjun ^{[1
]}

Yang, Gensheng ^{[1
]}

机构：

[1] College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou,310014, China

来源：

Food and Function | 2022年 / 13卷 / 11期

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Escherichia coli NISSLE 1917 (EcN) is a Gram-negative strain with many prominent probiotic properties in the treatment of intestinal diseases such as diarrhea and inflammatory bowel disease (IBD), in particular ulcerative colitis. EcN not only exhibits antagonistic effects on a variety of intestinal pathogenic bacteria, but also regulates the secretion of immune factors in vivo and enhances the ability of host immunity. In this review, the mechanisms of EcN in the remission of inflammatory bowel disease are proposed and recent advances on the functionalized EcN are compiled to provide novel therapeutic strategies for the prevention and treatment of IBD. © 2022 The Royal Society of Chemistry

引用

页码：5914 / 5924

共 50 条

[21] Escherichia coli Nissle 1917 for probiotic use in piglets: evidence for intestinal colonization
Barth, S.
Duncker, S.
Hempe, J.
Breves, G.
Baljer, G.
Bauerfeind, R.
JOURNAL OF APPLIED MICROBIOLOGY, 2009, 107 (05) : 1697 - 1710
[22] Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV
Ava Behrouzi
Hoora Mazaheri
Sarvenaz Falsafi
Zahra Hoseini Tavassol
Arfa Moshiri
Seyed Davar Siadat
Journal of Diabetes & Metabolic Disorders, 2020, 19 : 597 - 604
[23] Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917
Teresa Pérez-Berezo
Julien Pujo
Patricia Martin
Pauline Le Faouder
Jean-Marie Galano
Alexandre Guy
Claude Knauf
Jean Claude Tabet
Sophie Tronnet
Frederick Barreau
Maud Heuillet
Gilles Dietrich
Justine Bertrand-Michel
Thierry Durand
Eric Oswald
Nicolas Cenac
Nature Communications, 8
[24] Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV
Behrouzi, Ava
Mazaheri, Hoora
Falsafi, Sarvenaz
Tavassol, Zahra Hoseini
Moshiri, Arfa
Siadat, Seyed Davar
JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2020, 19 (01) : 597 - 604
[25] Utilizing and engineering the probiotic strain Escherichia coli Nissle 1917 for oral vaccination
Liebrecht, S.
Humberg, V.
Daudel, D.
Buddenborg, C.
Greune, L.
Schmidt, M. A.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2008, 298 : 96 - 96
[26] Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917
Grozdanov, L
Raasch, C
Schulze, E
Sonnenborn, U
Gottschalk, G
Hacker, J
Dobrindt, U
JOURNAL OF BACTERIOLOGY, 2004, 186 (16) : 5432 - 5441
[27] Probiotic Escherichia coli Nissle 1917 inhibits bacterial persisters that survive fluoroquinolone treatment
Hare, Patricia J.
Englander, Hanna E.
Mok, Wendy W. K.
JOURNAL OF APPLIED MICROBIOLOGY, 2022, 132 (06) : 4020 - 4032
[28] Detection and distribution of probiotic Escherichia coli Nissle 1917 clones in swine herds in Germany
Kleta, S.
Steinrück, H.
Breves, G.
Duncker, S.
Laturnus, C.
Wieler, L.H.
Schierack, P.
Journal of Applied Microbiology, 2006, 101 (06): : 1357 - 1366
[29] Probiotic Escherichia coli strain Nissle 1917-Pre-clinical evaluation of genotoxicity
Stiller, S.
Freitag, C.
Allingham, P.
Weber, K.
Mueller, S.
Von Bunau, R.
Schimiczek, M.
TOXICOLOGY LETTERS, 2022, 368 : S150 - S151
[30] Administration of a probiotic Escherichia coli Nissle 1917 increases the bioavailability of amiodarone in male rat
Matuskova, Z.
Zacharova, A.
Anzenbacherova, E.
Vecera, R.
Urbanek, K.
Kolar, M.
Tlaskalova-Hogenova, H.
Anzenbacher, P.
FEBS JOURNAL, 2012, 279 : 403 - 403

← 1 2 3 4 5 →